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Functional recovery in the end target muscle is a determinant of outcome after peripheral nerve injury. The neuromuscular
junction (NMJ) provides the interface between nerve and muscle and includes non-myelinating terminal Schwann cells (tSCs).
After nerve injury, tSCs extend cytoplasmic processes between NMJs to guide axon growth and NMJ reinnervation. The mech-
anisms related to NMJ reinnervation are not known. We used multiple mouse models to investigate the mechanisms of NMJ
reinnervation in both sexes, specifically whether macrophage-derived vascular endothelial growth factor-A (Vegf-A) is crucial
to establishing NMJ reinnervation at the end target muscle. Both macrophage number and Vegf-A expression increased in
end target muscles after nerve injury and repair. In mice with impaired recruitment of macrophages and monocytes (Ccr22/2
mice), the absence of CD681 cells (macrophages) in the muscle resulted in diminished muscle function. Using a Vegf-receptor 2
(VegfR2) inhibitor (cabozantinib; CBZ) via oral gavage in wild-type (WT) mice resulted in reduced tSC cytoplasmic process exten-
sion and decreased NMJ reinnervation compared with saline controls. Mice with Vegf-A conditionally knocked out in macrophages
(Vegf-Afl/fl; LysMCre mice) demonstrated a more prolonged detrimental effect on NMJ reinnervation and worse functional muscle re-
covery. Together, these results show that contributions of the immune system are integral for NMJ reinnervation and functional
muscle recovery after nerve injury.
Key words: muscle recovery; nerve injury; neuromuscular junction; reinnervation; terminal Schwann cell; vascular endo-
thelial growth factor
Significance Statement
This work demonstrates beneficial contributions of a macrophage-mediated response for neuromuscular junction (NMJ) rein-
nervation following nerve injury and repair. Macrophage recruitment occurred at the NMJ, distant from the nerve injury site,
to support functional recovery at the muscle. We have shown hindered terminal Schwann cell (tSC) injury response and NMJ
recovery with inhibition of: (1) macrophage recruitment after injury; (2) vascular endothelial growth factor receptor 2
(VegfR2) signaling; and (3) Vegf secretion from macrophages. We conclude that macrophage-derived Vegf is a key component
of NMJ recovery after injury. Determining the mechanisms active at the end target muscle after motor nerve injury reveals
new therapeutic targets that may translate to improve motor recovery following nerve injury.
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Introduction
Peripheral nerve injuries are common and devastating, dis-
proportionately affecting young, healthy people (Grinsell and
Keating, 2014). Although the peripheral nervous system is
unique from the central nervous system in that it has the capacity
to regenerate after injury, patient outcomes are often unsatisfac-
tory (Novak et al., 2009; Ciaramitaro et al., 2010). Important
factors predicting recovery from nerve injury include injury se-
verity, duration, and location; patient age and health; and man-
agement approach (Boyd et al., 2011; Novak et al., 2011).
Despite advancements in our understanding of the mechanisms
contributing to nerve regeneration, further investigation is war-
ranted to improve clinical outcomes. Comprehensive study of
the entire system encompassing the neuronal cell body, axons,
neuromuscular junction (NMJ), and end target muscle is neces-
sary to understand the mechanisms contributing to repair and
recovery.
Axonal regeneration across a nerve transection site has been
shown to be largely driven by immune-mediated mechanisms
(Cattin et al., 2015). Within hours of injury, calcium accumula-
tion drives Wallerian degeneration resulting in axonal and mye-
lin fragmentation distal to the injury site (Burnett and Zager,
2004; Faroni et al., 2015). Axonal debris leads to resident macro-
phage activation and circulating monocyte recruitment to the
nerve injury site (Lech and Anders, 2013). Monocytes differenti-
ate into macrophages after migration. Different macrophage
phenotypes secrete factors integral to healing (Tomlinson et al.,
2018), including vascular endothelial growth factor (VEGF), a
key regulator of angiogenesis (Nissen et al., 1998; Stockmann et
al., 2011; Shvartsman et al., 2014). Angiogenesis results in newly-
formed blood vessels lined with endothelial cells (ECs) that guide
myelinating Schwann cells (SCs), which then guide regenerating
axons across a nerve injury site. Induced myeloid cell depletion
has a net negative effect, compromising axonal regeneration and
Figure 1. Increased leukocytes are present in the end target muscle following peripheral nerve injury in WT mice. A–C, Lymphocyte (CD451, arrows) cell numbers significantly increased
after nerve injury compared with naive, uninjured muscles and peaked at day 14. D–F, Macrophage (CD681, arrows) cell numbers were significantly higher than in naive muscles at all time
points from days 3 to 21 postinjury. G, Flow cytometry revealed peak cell numbers in lymphocytes and macrophages at days 3 and 14 after nerve injury. H, Gene expressions of the Ccr2
ligands, chemokine-ligand-2 (Ccl2) and chemokine-ligand-8 (Ccl8), were significantly higher at days 3 and 14, respectively, compared with naive muscles. Ccl8 remained elevated at day 21.
A, B, CD45 Ab = lymphocytes (green). D, E, CD68 Ab = macrophages (red), S100 Ab = glial cells (green), BTX = a-bungarotoxin (endplates, purple), DAPI = nuclear staining (blue). Scale
bars: 20mm (A, B) and 50mm (D, E). Data: mean6 SD; N= 3–4 mice/time point; pp, 0.05.
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recovery of motor function, highlighting
the importance of myeloid cells to the
milieu supporting axonal regeneration
(Barrette et al., 2008).
While these cellular mechanisms con-
tributing to axonal regeneration in the
nerve are well described, analogous mecha-
nisms contributing to NMJ reinnervation
have not been reported. Functional outcome
after nerve injury is ultimately dependent
on successful target muscle reinnervation at
the NMJ. The NMJ represents the interface
of nerve and muscle and consists of three
main components: the nerve terminal,
which releases acetylcholine (ACh) vesicles
across the synaptic cleft, the postsynaptic
motor endplates, or ACh receptors (AChRs),
and one to three terminal SCs (tSCs; or
perisynaptic SCs) that encompass the
entire NMJ (Kang et al., 2003; Wilson and
Deschenes, 2005; Smith et al., 2013;
Santosa et al., 2018; Snyder-Warwick et
al., 2018). These non-myelinating tSCs
contribute to NMJ maintenance, signal-
ing, and repair (Son and Thompson, 1995;
Kang et al., 2014). After nerve injury, tSCs
extend long processes to facilitate axon
sprouting and guidance to the NMJ (Kang
et al., 2014), but the contributions of tSCs
to NMJ recovery following nerve injury are not fully under-
stood. Specifically, interactions of tSCs with an immune
response to facilitate NMJ recovery have not been reported. In
this study, we demonstrate that an immune response occurs at
the NMJ following nerve transection and repair. Specifically, we
note an increase in macrophages and Vegf-A at the NMJ after
nerve injury. We show that inhibition of: (1) macrophage
recruitment; (2) Vegf-receptor 2 (VegfR2) signaling; and (3)
macrophage-derived Vegf-A secretion all result in diminished
tSC injury response and NMJ recovery.
Materials and Methods
Animals
All mice were housed in a central animal facility and were maintained
preoperatively and postoperatively in strict accordance with the National
Institutes of Health guidelines and according to protocols approved
by the institutional animal research ethics committee (IACUC) at
Washington University School of Medicine in St. Louis. For all experi-
ments, adult (12- to 16-week-old) mice of both sexes were analyzed.
Wild-type (WT; pure C57BL/6 background) mice were bred in our
laboratory. Chemokine receptor 2 (Ccr2) constitutive knock-out mice,
Ccr2/ (Willenborg et al., 2012), kindly provided by Gwendolyn
Randolph (Washington University, St. Louis, MO), were used as a model
lacking the ability to recruit monocytes and macrophages to injury sites
and were bred in our lab. To generate a conditional knock-out of Vegf-A
specifically in macrophages, Vegf-Afl/fl; LysMCre mice were crossed to
Vegf-Afl/fl mice (Gerber et al., 1999) and compared with Vegf-Afl/fl con-
trols. Vegf-Afl/fl mice were generously provided by Matthew Silva
(Washington University, St. Louis) and LysMCremice (Clausen et al., 1999),
in which the LysM gene drives Cre expression in macrophages, were kindly
provided by Roberta Faccio (Washington University, St. Louis) and
Benjamin Levi (University of Michigan). To assess VegfR2 (also known as
Flk-1), Flk-1Cre; Rosa 26 tdTomato mice were generous provided by David
Ornitz (Washington University, St. Louis; Motoike et al., 2003). Mutant
mice were genotyped by the TAG Center of Transnetyx.
Surgical procedure for sciatic nerve injury and repair
Animals were anesthetized to an appropriate level via intraperitoneal ke-
tamine and dexmedetomidine cocktail (50mg/kg). Buprenorphine-SR
(1.0mg/kg) and saline were administered for postoperative pain control
and hydration, respectively. The sciatic nerve from the right hindlimb
was sharply transected and an immediate epineurial repair was per-
formed with microsutures under a standard operating microscope as
described previously (Vannucci et al., 2019). Animals were then placed
on a heating pad, and anesthesia was reversed with Antisedan
(0.5 mg/kg).
Cabozantinib (CBZ) administration
To determine the effect of lack of VegfR2 signaling, CBZ (XL184,
MedChemExpress), a VegfR2 inhibitor (Yakes et al., 2011; Haider et al.,
2015), was diluted in saline and administered via oral gavage beginning
6 d after nerve injury and repair as muscle Vegf-A expression begins to
peak at 10d postinjury and regenerating axons do not reach the NMJ
until about that same time. WT mice were randomized to receive either
100mg/kg of CBZ (200ml/d) or saline control (200ml/d) for 7 d (days 6–
13 following nerve injury and repair). Mice were then killed 14, 21, and
28d after nerve injury (n= 3 mice/treatment/time point).
Muscle harvest and immunocytochemistry
At the designated time points (3–42d postinjury), mice were anesthe-
tized with intraperitoneal ketamine cocktail and then killed. The tibialis
anterior (TA), extensor hallucis longus (EHL), and extensor digitorum
longus (EDL) muscles were harvested from the injured and uninjured
legs of the animal as described previously (Vannucci et al., 2019).
To evaluate macrophage markers (CD68), Vegf-A, and VegfR2 pro-
tein expression, muscles were fixed in 4% paraformaldehyde (PFA).
Frozen sections (25mm thick) were immunostained as described previ-
ously (Snyder-Warwick et al., 2018). The primary antibodies used
include: mouse anti-VEGF-A (1:1200, Abcam catalog #ab1316, RRID:
AB_299738), mouse anti-VegfR2 (1:200, Cell Signaling Technology cata-
log #2479, RRID:AB_2212507), rat anti-CD68 (1:500, Bio-Rad catalog
#MCA1957, RRID:AB_322219), and rat anti-CD45 (1:100, BD Biosciences
catalog #550539, RRID:AB_2174426).
Figure 2. Ccr2/ mice have impaired macrophage recruitment to the NMJ. A, Flow cytometry showed a comparable
number of macrophages/muscle in naive, uninjured WT, and Ccr2/ mice. B–D, WT mice showed increased CD681
macrophages/image area (green, arrows) around the NMJ 5 d after nerve injury, while Ccr2/ mice had nearly no mac-
rophage presence at the NMJ 5 d after nerve injury. CD68 Ab = macrophages (green), BTX = a-bungarotoxin (endplates,
red), DAPI = nuclear staining (blue). Scale bar: 50mm (C, D). Data: mean 6 SD; N= 3–4 mice/genotype/time point;
pp, 0.05.
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To evaluate axonal reinnervation and tSC process extensions, EHL
and EDL muscles fixed in 2% PFA were mounted on slides as previously
described (Jablonka-Shariff et al., 2019; Vannucci et al., 2019). Whole
mounted muscles were stained with rabbit anti-NF200 (1:400; Sigma-
Aldrich catalog #N4142, RRID:AB_477272) or rabbit anti-S100 (1:10;
Agilent catalog #Z0311, RRID:AB_10013383) overnight at 4°C. Both
frozen sections and the whole mounts were incubated in secondary
antibodies Alexa Fluor 488 nm or Alexa Fluor 594 nm (1:1000; Life
Technologies). Tissues were further incubated with a-bungarotoxin
(aBTX) Alexa Fluor 555 (aBTX, 1:1000, Thermo Fisher Scientific cata-
log #B35451, RRID:AB_2617152) or Alexa Fluor 647 aBTX (1:1000).
aBTX binds specifically to AChRs in the postsynaptic membrane.
Muscles were mounted on glass slides using Vectashield mounting me-
dium with DAPI (Vector Laboratories catalog #H-1200, RRID:AB_
2336790).
Morphometric evaluation
All muscles were imaged under 20 magnifi-
cation with an Axio Imager M2 fluorescent
microscope (Zeiss). Images with a total area of
445.54 333.66 mm2 were analyzed using NIH
ImageJ (https://imagej.nih.gov/ij/), and figures
were prepared using Adobe Photoshop CC 2018
and Adobe Illustrator CC 2018 system (Adobe
Systems). For quantitative analyses, muscle sec-
tions from at least three animals per group were
processed, and at least five random sections,
totaling.100 NMJs were analyzed per muscle.
aBTX was used to stain AChRs, S100 anti-
body was used to label all SCs (myelinating
and non-myelinating), and NF200 antibody la-
beled neurofilament/axons. CD45 and CD68
were used to mark leukocytes and macro-
phages, respectively. The number of CD451
and CD681 cells were counted per field of
view. Vegf-A protein expression was calculated
as the percent of total area of the image ana-
lyzed. ImageJ macro was used to quantify
Vegf-A expression. The percentage of the area
in a standard field that was positive for Vegf-A
was measured by the software. Images used for
measurements were collected with similar mi-
croscopic settings for experimental and control
groups. For endplate reinnervation and tSC
process extensions, only the most superficial
muscle layers were evaluated as previously
described (Vannucci et al., 2019). NMJ rein-
nervation was defined as the colocalization of
the nerve terminal stained with NF200 and
AChRs stained with aBTX. NMJs were consid-
ered fully reinnervated if endplates were75%
covered with NF200 staining. Partial NMJ
reinnervation was defined as colocalization of
BTX and NF200 staining, but with,75% cov-
erage. No reinnervation, or denervation was
defined as no NF200 staining present over
BTX. Presence of tSC processes was defined as
extension of the tSC cytoplasm branching out-
side the boundaries of the original motor end
plates. The percentage of NMJs with tSC proc-
esses was evaluated after staining with S100.
All evaluations were performed in a blinded
fashion by three independent investigators.
Functional muscle recovery assessments
Functional TA muscle recovery was assessed at
14, 21, and 28d after nerve injury and repair,
before tissue harvest, using compound muscle
action potentials (CMAPs) using FASt System,
Red Rock Laboratories (Bogdanik et al., 2015;
Vannucci et al., 2019). After anesthesia was
induced, the sciatic nerve was exposed, and the
previous nerve repair site was identified. The stimulating electrode was
placed under the sciatic nerve at a location 10 mm proximal to the injury
site. Two receiving electrodes were placed transcutaneously into the TA
muscle belly, and the ground electrode was attached to a different part of
body. After stimulation at 50Hz CMAPs amplitudes were recorded. For
comparison, CMAPs were also measured at the contralateral uninjured
side. The CMAPs with the maximal peak-to-peak peak amplitudes (in
mV) were calculated for every mouse (n=2 or more mice per group per
time point).
Tissue processing for flow cytometry
To analyze the immune cell composition within muscle at days 3, 7, 14,
and 21 after nerve injury, muscles from the affected hindlimb were
Figure 3. Ccr2/ mice exhibit decreased NMJ reinnervation and diminished muscle function following nerve injury and
repair. A, B, WT and Ccr2/ mice have normal NMJ morphology and innervation (arrows) in naive, uninjured muscles.
C, D, NMJ reinnervation, represented by colocalization of neurofilament and motor endplate staining (arrows), was signifi-
cantly decreased in Ccr2/ mice compared with WT mice at 14 d after nerve injury and repair. A significant difference in
innervation remained at 21 d (images not shown), but was mitigated by 28 d (E, F). G, Bar graph summarizes the quantita-
tive findings according to full, partial, or no NMJ innervation (none). H, Evoked CMAPs of the TA muscle were significantly
lower in Ccr2/ mice compared with WT mice at 28 d after nerve injury and repair, despite no difference in reinnervation
at that time point. NF200 Ab = axons (green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale
bar: 50mm. Data: mean6 SD; N= 3–6 mice/genotype/time point; pp, 0.05.
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collected from WT and Ccr2/ mice for colla-
genase digestion and leukocyte isolation using
modifications of published procedures (Kuswanto
et al., 2016; Pan et al., 2019). Muscles used for anal-
ysis included the majority of muscles innervated
by sciatic nerve (TA, peroneus tertius, PL, PB, gas-
trocnemius, plantaris, soleus, tibialis posterior,
FHL, FDL, and popliteus). For each flow cytomet-
ric sample, muscles from two hind limbs, i.e.,
affected muscles from two mice, were pooled.
Muscles were minced, followed by digestion with
1mg/ml Collagenase II and 10mg/ml DNase I
(both from Sigma Aldrich) in RPMI 1640 media
containing 2% fetal calf serum, for 45min at 37°C.
Remaining tissue pieces were then dissociated
through a 100-mm cell strainer, and the resulting
cell suspension was centrifuged at 500  g.
Immune cells were then enriched by Percoll gradi-
ent centrifugation, for which cells were resus-
pended in 40% Percoll, overlayed over 70% Percoll
(GE Healthcare), and centrifuged for 20min at 850
 g at 4°C without brake. The interphase was then
washed with HBSS containing 10% calf serum, fil-
tered through 70mm, and resuspended in FACS
buffer (PBS with 2% calf serum and 0.01% NaN3).
Nucleated cell counts and cell viability were deter-
mined by diluting cell suspensions with a mixture
of acridine orange and propidium iodide and ana-
lyzing on a K2 Cellometer (Nexcelom).
Flow cytometry was performed using stand-
ard procedures (Fuchs et al., 2019). In short,
enriched immune cells were incubated with
TruStain FcX (anti-mouse CD16/32, Biolegend)
to block Fc receptors for 10min on ice, before
staining with fluorochrome-conjugated antibod-
ies. Antibodies used were purchased from BD
Bioscience: CD45-BV510 (clone 30-F11), Siglec
F-PE/CF594 (E50-2440), CD64-PE (X54-5/
7.1.1); from Biolegend: CD11b-PerCP-Cy5.5
(M1/70), Ly6C-BV421 (HK1.4), Ly6G-Alexa
Fluor 700 (1A8), and from R&D Systems:
MerTK-biotin (polyclonal). MerTK-biotin was
detected with PE/Cy7-conjugated streptavidin
(BD Biosciences). Dead cells were excluded by staining with fixable live/
dead dye (Zombie NIR, Biolegend). Samples were acquired on an LSR
Fortessa equipped with four lasers (488, 405, 640, and 552 nm) using
the Diva software (all from BD Biosciences), and data were analyzed
with FlowJo 10 (Treestar Inc.). Macrophages were identified as CD451
CD11b1 CD641 MerTK1; monocytes were gated as CD451 CD11b1
Ly6C1 Ly6G– CD64– Siglec F– SSClow-med. Cell concentrations in
stained samples were determined by adding counting beads to the
samples immediately before flow cytometric acquisition (123count
eBeads, eBioscience). Cell concentrations in samples were calculated
per manufacturer’s directions and were used to determine the cell
counts in muscle from two hind limbs.
RNA extraction and quantitative PCR
TA muscles were dissected and immediately placed in RNALater solu-
tion (Thermo Fisher Scientific), homogenized in TRIzol (Invitrogen),
and stored at 80°C. Total extracted RNA was treated with RNase-free
DNase (QIAGEN). The RNA pellet was further purified using
RNeasy MinElute Cleanup kit (QIAGEN) according to the manufac-
turer’s protocols and quantified with a NanoDrop ND-1000 spectro-
photometer. Sample quality was evaluated with the 260 nm/280 nm
ratio. Complementary DNA was synthesized from total RNA
(100 mg) using High-Capacity cDNA Transverse Transcription kit
(Applied Biosystems). Samples without reverse transcriptase (RT)
enzyme, to control for genomic DNA contamination, were also
included. RNA was extracted from at least 2 animals per group in the
different models of the study.
Quantitative real-time PCR (qRT-PCR) was performed using
TaqMan Fast Universal PCR Master mix and specific TaqMan PCR pri-
mers-probes combination were purchased from Applied Biosystems.
Vegf-A (Mm00437306-m1) and Gapdh (Mm99999915-g1) Taq-Man
Gene Expression Assays were used. All qPCR studies were performed on
a Step One Plus instrument (Applied Biosystems), and results were ana-
lyzed using Microsoft Excel and DDCt method (Livak and Schmittgen,
2001). Relative expression levels were calculated for the Vegf-A gene by
normalizing first to Gapdh level and then to the expression in sham
uninjured muscle for each mouse genotype. Relative gene expression for
muscle on the injured side is shown as fold change compared with the
uninjured side. Samples were run in triplicate, and “non-template con-
trols” with water and no RT enzyme were conducted as negative controls.
Statistical analysis
Continuous variables were reported as mean 6 SD, while categorical
variables were reported in percentages. Quantification of reinnervation
and tSC process extension were performed in a blinded fashion with
three independent evaluators, with three mice used per experimental
group in every time point. Two-tailed, unpaired Student’s t tests were
used to assess statistical differences between continuous variable data-
sets, while x 2 tests were used for categorical variables. Statistical signifi-
cance was set at p, 0.05. Statistical analyses were performed using
GraphPad Prism 8 (GraphPad Software).
Figure 4. Vegf-A expression increases in the end target muscle following nerve injury in WT mice. A, Immunostaining
of Vegf-A protein (pseudocolored in gray, arrows) was nearly undetectable in naive, uninjured muscles. B–D, From the 3rd
to the 12th day postinjury, Vegf-A expression steadily increased. E, The increasing Vegf-A protein expression/image area
under 20 magnification was quantitatively summarized for all time points. Vegf-A Ab (gray). Scale bar: 50mm. Data:
mean6 SD; N= 3 mice/time point; pp, 0.05.
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Results
An immune response occurs at the NMJ in the end target
muscle following nerve injury
After sciatic nerve transection and repair, increased leukocytes
(CD451) and macrophages (CD681) were found in the EDL
muscles from WT mice within the first two weeks after nerve
injury and repair (Fig. 1A–G). Both leukocyte and macrophage
(defined as CD45, CD11b, CD64, and MerTK positivity) cell
numbers peaked within the first 14 d after nerve injury and
repair via whole muscle flow cytometry (Fig. 1G), although sig-
nificant differences were noted only at day 3: macrophages day 3
versus naive, p, 0.00502; monocytes day 3 versus naive, p ,
0.0035; lymphocytes day 3 versus naive, p , 0.0466. Quanti-
tative analysis of immunostaining showed persistently elevated
CD451 and CD681 cell numbers near the NMJ from days 3 to
21 after nerve injury and repair. Increased mRNA expression of
the Ccr2 receptor ligands, chemokine-ligand-2 (Ccl2; at 3 d after
nerve injury) and chemokine-ligand-8 (Ccl8; at 14 d after nerve
injury), were significantly higher than naive muscles (Ccl2 vs naive
at 3 d: p, 0.0304; Ccl8 vs naive at 14d: p=0.0004, 21 d:
p=0.0009; Fig. 1H). The peaks in cytokine
expression levels at 3 and 14d postinjury
correlate with peaks in monocyte and mac-
rophage numbers within those same time
points.
The Ccr22/2mouse exhibits decreased
NMJ reinnervation and diminished
muscle function following nerve injury
and repair
Given the robust immune response within
the muscle of the WTmice following nerve
injury, we further assessed the role of mac-
rophages at the NMJ following nerve injury
in the Ccr2/ mouse, which lacks a
major mechanism of monocyte and macro-
phage recruitment. Macrophage numbers
did not differ at baseline between WT and
Ccr2/ mice (Fig. 2). Ccr2/ mice
were confirmed to have significantly
(p, 0.000001) diminished macrophage
recruitment to the NMJ after injury, how-
ever (Fig. 2). Ccr2/ mice demonstrated
overall normal NMJ morphology in naive
muscle compared with WT mice (Fig. 3A,
B), and performance on a walking grid test
did not differ from uninjured WT mice
(Wood MD, unpublished data). After
nerve transection and repair, NMJ reinner-
vation was significantly decreased in
Ccr2/ mice compared with controls at
14 and 21d postinjury (Fig. 3). Sig-
nificantly less partial (p, 0.0052) and
significantly more denervation (none, p ,
0.0043) were noted at 14 d postinjury in
the Ccr2/mice compared with WT and
21d after injury (p, 0.0276 for partial,
p, 0.0005 for none). Quantitative differ-
ences in NMJ reinnervation mitigated by
28d postinjury in all categories of innerva-
tion (Fig. 3G). In addition to morphologic
reinnervation differences, Ccr2/ mice
exhibited diminished muscle function com-
pared with WT mice at 28d after nerve
injury and repair. CMAP amplitudes were significantly lower (p =
0.035) for Ccr2/mice (9.176 1.3mV) compared withWTmice
(10.91 6 1.1mV), despite equivalent reinnervation at this time
point (Fig. 3H).
Vegf-A expression increases in the end target muscle after
nerve injury
A critical role of macrophages after nerve injury is promoting
formation of blood vessels that guide SCs to migrate across nerve
gaps and mediate axonal regeneration (Cattin et al., 2015).
Macrophages secrete Vegf-A, which promotes angiogenesis (Fantin
et al., 2010) and may also recruit more macrophages from the
blood stream (Cursiefen et al., 2004). Given the association of
Vegf-A with macrophages, we hypothesized its presence in
muscle is strongly correlated with NMJ reinnervation after
nerve injury. Nearly undetectable Vegf-A protein levels were
observed in muscles that were uninjured and following 1 d after
nerve injury. By the third day postinjury, Vegf-A expression
Figure 5. VegfR2 is expressed in tSC cytoplasm and processes connecting cell bodies after nerve injury. In order to deter-
mine VegfR2 localization, we used Flk-1Cre; Rosa26tdTomato mice, where Rosa26TdTomato staining (red) is present at locations
of VegfR2 (Flk-1) expression. A, In naive muscles without previous nerve injury, VegfR2 was located on ECs (white arrows)
but not in tSCs or around NMJs. B, At day 6 after nerve injury and repair, the NMJ with tSCs was surrounded by VegfR2-
expressing ECs (white arrow). C, D, At higher magnifications, VegfR2 localized within tSC cell bodies and cytoplasmic proc-
esses (yellow arrows) in addition to ECs. The single channel insets, pseudocolored in gray, highlight the positive staining of
VegfR2 within the tSCs and tSC processes (yellow arrows). E, F, Colocalization of S100 staining (glia) with anti-Flk1 is seen
at tSCs at 6 d postinjury. The inset (E) represents a single red channel pseudocolored in gray showing the positive staining
of VegfR2 in tSCs. Immunostaining for BTX (endplates, yellow stars) in panels A–D are shown as insets pseudocolored in
gray. These single-channel images represent BTX staining of the area shown in color. Flk-1 = VegfR2 (red), S100 Ab = glial
cells (green), DAPI = nuclear staining (blue). N= 3 mice/time point. Scale bars: 50mm (A, B) and 20mm (C, D).
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increased significantly (p= 0.0157) compared with uninjured
muscles, and peaked at day 14 (p, 0.001; Fig. 4).
VegfR2 inhibition results in fewer Vegf-A-secreting
macrophages at the NMJ
Given the increased Vegf-A expression in the end target muscle
following nerve injury, we investigated VegfR2 expression and
signaling. VegfR2 localization was performed using the Flk1Cre;
TdTomato mouse, which exhibits Rosa staining at locations of
VegfR2 (Sierra-Filardi et al., 2014). VegfR2 was noted within
ECs of the blood vessels, tSCs, and nerve terminals at 6 d af-
ter nerve injury and repair (Fig. 5). We also investigated the
impact of VegfR2 signaling inhibition with the VegfR2 inhib-
itor, CBZ. To determine the presence of a feedback loop for
inhibition of VEGFR2 signaling, we evaluated VEGF-A lev-
els, macrophages (CD681 cells), and CD681, Vegf-A1 cells.
CBZ administration to WT mice resulted in immediate,
temporarily decreased Vegf-A protein expression in the
muscles after nerve injury compared with saline-gavaged
mice at 14 d (CBZ = 1.63, saline = 3.33, p, 0.001; Fig. 6A).
Vegf-A mRNA expression levels were lower in the muscle of
the nerve-injured hindlimb relative to the uninjured side in
the CBZ group compared with controls at both 14 d (CBZ =
1.65, saline = 2.37, p, 0.001) and 21 d (CBZ = 1.73, saline =
3.89, p, 0.001; Fig. 6B). Macrophage (CD681 cells) num-
bers were significantly lower in the CBZ mice across all time
points (Fig. 6C–E). Co-staining of Vegf-A with CD68 (Fig.
6F,G,F’,G’) revealed a significantly lower percentage of Vegf-
A1, CD681 cells in the CBZ group at 14 d (CBZ = 63.46%,
saline = 85.52%, p = 0.004), indicating the presence of fewer
Vegf-A-secreting macrophages (Fig. 6F–H). The number
of cells co-staining with Vegf-A and CD68 were similar
between CBZ-treated mice and controls at 21 d (p = 0.67),
reflecting the transient effect of the CBZ treatment. Vegf-A
Figure 6. VegfR2 inhibition decreases Vegf-A expression and macrophage cell numbers after nerve injury. A, CBZ, a VegfR2 inhibitor, treatment (daily from days 6 to 13 fol-
lowing nerve injury) decreased Vegf-A protein expression at 14 d after nerve injury compared with saline-gavaged control mice. B, In control mice, Vegf-A mRNA expression
was elevated by 14 d postinjury, peaked at 21 d, and returned to baseline by 28 d. CBZ inhibited Vegf-A mRNA expression at days 14 and 21 postinjury, but the effect was
not sustained by day 28. C–E, CBZ resulted in significantly decreased macrophage numbers at all time points. Arrows point to CD681 cells (pseudocolored in gray in C, D).
a-Bungarotoxin staining of (BTX purple) demonstrates relationship of macrophages near NMJs. F–H, The percent of macrophages (green) colocalizing (arrows) with Vegf-A
(red) was significantly less in the CBZ-treated group than saline-treated controls at day 14. The magnified images of single cells in F’, G’ highlight the colocalization of Vegf-
A with a macrophages via isolated color channels. Vegf-A Ab (red), CD68 Ab = macrophages (green), BTX = a-bungarotoxin (endplates, purple), DAPI = nuclear staining
(blue). Scale bar: 20mm. Data: mean 6 SD; N = 3–5 mice/treatment/time point; pp, 0.05.
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mRNA and the percentage of CD681, Vegf-A1 cells
increased in CBZ treated mice at 28 d, reflecting the transient
nature of the inhibitor and a return to baseline values.
VegfR2 (Flk-1) inhibition reduces tSC cytoplasmic process
extension and NMJ reinnervation
We hypothesized that Vegf-A supports NMJ reinnervation by
guiding tSC process extension after nerve injury. tSC process
extension was significantly (p, 0.05) decreased in the CBZ
group (11%) at 14 d, as compared with the saline control group
(22%; Fig. 7). At 21 d, the difference was no longer significant,
which we suspect is related to the temporary effects of the drug.
Morphologically, the tSC processes were shorter in length (Fig.
7B) in the CBZ group at 14 d after nerve injury but at 21 d the
tSCs were still able to form processes (Fig. 7D). NMJ reinnerva-
tion was significantly decreased in the CBZ group compared
with controls at 14 d postinjury when partial and full innervation
were grouped together (CBZ 18.7%, saline 34.1%, p = 0.048), but
did not significantly differ in the three categories of full (CBZ
3.1%, saline 10.2%, p, 0.29), partial (CBZ 15.6%, saline 24.0%,
p, 0.28), and none (CBZ 81.3%, saline 65.9%, p, 0.20) as large
standard deviations were noted in some
groups. There were no differences in rein-
nervation between the CBZ and control
groups at 21 or 28 d (Fig. 8), reflecting the
temporary effects of CBZ. Electrophy-
siological testing by CMAP showed no sig-
nificant differences between the two groups
at all time points (Fig. 8H). The results
show that Vegf-A in the muscle is intri-
cately correlated with tSC function and
NMJ reinnervation, but not muscle
function.
Vegf-Afl/fl; LysMCremice have a lower
percentage of Vegf-A-secreting
macrophages near the NMJ following
nerve injury and repair
VegfR2 inhibitor, CBZ, has limited bioa-
vailability, short bioactivity, and non-speci-
ficity. To better assess the impact of Vegf-A
on reinnervation, then, we used a trans-
genic model with conditional knock-out of
Vegf-A specifically in macrophages using
Vegf-Afl/fl; LysMCre mice. Vegf-Afl/fl mice
were used as controls for comparison.
Vegf-A protein expression in the muscles
of Vegf-Afl/fl; LysMCre mice was significantly
decreased at 14 d (p, 0.001) and 21d
(p=0.011) after nerve injury (Fig. 9A).
Vegf-A gene expression via qPCR in TA
muscles showed incremental increases
from 7 to 28d after nerve injury in control
mice, whereas significantly (p=0.011)
lower levels of Vegf-A mRNA expression
were seen in the TA muscles of Vegf-Afl/fl;
LysMCre mice at 7, 14, and 28d postinjury
compared with control mice. In Vegf-Afl/fl;
LysMCre mice, muscle Vegf-A mRNA levels
peaked at 21d after nerve injury and then
again decreased by 28d (Fig. 9B). Unlike the
CBZ model, CD681 macrophage counts
near the NMJ after nerve injury in Vegf-Afl/fl;
LysMCre mice were either higher (days 7 and
28, p, 0.05) or comparable (days 14 and 21) to control mice (Fig.
9C–G). Co-staining of Vegf-A with CD68 in the muscles (Fig. 9H)
revealed a significantly lower percentage of CD681 cells expressing
Vegf-A in theVegf-Afl/fl; LysMCremice at all time points, as expected
in this model. Vegf expression seen in the Vegf-Afl/fl; LysMCre mice
is contributed by ECs within blood vessels and inefficiency of the
conditional mutation, as a small number of macrophages continue
to express Vegf-A.
Vegf-Afl/fl; LysMCremice have fewer tSC processes,
diminished NMJ reinnervation, and poor functional recovery
following nerve injury and repair
Evaluation of tSC process extension showed significantly fewer
processes in Vegf-Afl/fl; LysMCre mice compared with controls at
all time points up to 21d after nerve repair (Fig. 10). By 28d, tSC
process extensions were observed in the Vegf-Afl/fl; LysMCre mice
(Fig. 10H), while the control mice showed less tSC communica-
tion between motor end plates, indicating potential withdrawal
of the tSC processes after successful reinnervation (Fig. 10G).
Full NMJ reinnervation was significantly less in the Vegf-Afl/fl;
Figure 7. VegfR2/Vegf-A inhibition reduces tSC process extension beyond NMJ area after nerve injury. A, B, tSC cyto-
plasmic processes in the CBZ-treated mice (yellow arrows) were absent, short, or fragmented, and extended from fewer
NMJs at day 14 compared with long tSC processes in saline-treated control mice (white arrows). The insets highlight long
tSC processes (white arrow) in saline-treated mice (A) and lack of processes (yellow arrow) in CBZ-treated mice (B). C, D,
This effect did not persist on day 21 postinjury and repair (8 d after the last dose of CBZ), as there was no difference
between CBZ-treated mice and controls relative to percent NMJs with tSC processes. E, Quantitatively, the percentage of
NMJs with tSC processes in CBZ-treated mice was half that of controls at 14 d and not significantly different from controls
at 21 d. S100Ab = glial cells (green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale
bar: 50mm. Data: mean6 SD; N= 3–5 mice/treatment/time point; pp, 0.05.
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LysMCre mice at 21 d (control 62.13%,
Vegf-Afl/fl; LysMCre 28.30%, p, 0.0036).
Denervation (none) was significantly
higher in the the Vegf-Afl/fl; LysMCre mice
at 21 d compared with controls (control
19.2%, Vegf-Afl/fl; LysMCre 58.8%, p ,
0.0272). By 28 d after nerve repair, when
tSC process extension continued to inc-
rease in Vegf-Afl/fl; LysMCre mice, full NMJ
reinnervation was nearly 80% in both
groups (Fig. 11). Despite equivalence of
morphologic reinnervation data at 28 d,
Vegf-Afl/fl; LysMCre mice demonstrated sig-
nificantly poorer CMAP performance at
this time point compared with control
mice (p= 0.0065), indicating a not only a
morphologic difference, but also functional
impact from macrophage-derived Vegf-A
deletion in the setting of nerve injury and
NMJ reinnervation.
Discussion
The immune response is important for
axonal regeneration at the nerve transec-
tion site (Cattin et al., 2015). In this study,
we show an immune response also occurs
in muscle and is integral to NMJ reinner-
vation following nerve injury. We first
showed an inflammatory response down-
stream from the injury, including mono-
cyte and macrophage recruitment to the
target muscle and increased Ccl2 and
Ccl8 expression, responsible for attracting
monocytes from bloodstream to target
muscle. The Ccr2/ mouse model
(impaired macrophage recruitment) showed
monocytes and macrophages are important
for NMJ reinnervation and end target mus-
cle function after nerve injury. Impaired
macrophage recruitment resulted in delayed
NMJ reinnervation and diminished muscle
function, even after NMJ reinnervation,
demonstrating innervation is not equivalent
to synaptic function. We showed Vegf-A
expression within muscle increased from
3d after nerve injury and repair, suggesting
neurons are not the source of Vegf-A. Vegf-
A levels are not elevated in uninjured WT
mice and increase before regenerating axons
reach the NMJ. Disruption of Vegf-A sig-
naling with VegfR2 inhibitor, CBZ, or using
a transgenic mouse model lacking macrophage-secreted Vegf-A,
resulted in fewer tSC cytoplasmic processes (which normally
extend after denervating injuries), decreased NMJ reinnerva-
tion, and diminished muscle function. These findings are note-
worthy as diminished or delayed NMJ reinnervation should
result in increased tSC process extension. In summary, we have
shown NMJ reinnervation hindrance with inhibition of the fol-
lowing: (1) macrophage recruitment; (2) VegfR2 signaling; and
(3) Vegf-A secretion from macrophages. We conclude that
macrophage-secreted Vegf-A is a key component of NMJ re-
covery after injury.
VegfR2 (or Flk-1), the receptor responsible for initiating
downstream Vegf-A pathways, is found in ECs, initiates angio-
genesis, and increases vessel permeability (Olsson et al., 2006). In
the nervous system, VegfR2 is expressed in neuronal cells (Krum
and Rosenstein, 1998; Park et al., 2016), SCs (Sondell et al.,
1999a,b), and ECs involved in posttraumatic or developmental
angiogenesis (Krum and Rosenstein, 1998; Rosenstein et al.,
1998). Interestingly, most studies focusing on VegfR2 effects have
been conducted on CNS tissue or cells. In the PNS, exogenous
Vegf-A has neurotrophic actions which can trigger neurite exten-
sion and promote axonal outgrowth in cultured ganglia cells
(Sondell et al., 1999b). In an in vivo model, nerve allografts
pretreated with Vegf-A showed enhanced SC growth and
Figure 8. VegfR2/Vegf-A inhibition reduces NMJ reinnervation after nerve injury. A, B, NMJ reinnervation,
defined as overlap of axonal staining (NF200 Ab, green) with a-bungarotoxin (BTX, endplates, red) staining
(arrows), was significantly less in CBZ-treated mice compared with controls at day 14, but not at days 21 (C,
D) or 28 (E, F) after nerve injury and repair. The insets highlight innervated endplate (A) and denervated end-
plate (B) in saline-treated and CBZ-treated mice, respectively. G, Quantification analyses showed both full and
partial NMJ reinnervation in CBZ-treated mice were approximately half the values of controls at 14 d postin-
jury. The percentage of fully reinnervated NMJs did not change from 21 to 28 d postinjury in the CBZ group. H,
There were no differences in CMAP amplitudes between CBZ-treated mice and saline-treated controls at all
time points postinjury. DAPI = nuclear staining (blue). Scale bar: 50mm. Data: mean 6 SD; N = 3–5 mice/
treatment/time point.
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neovascularization, and VegfR2 was identified in SCs within nerve
allograft (Sondell et al., 1999a). Raimondo et al. (2019) injected al-
ginate hydrogels secreting Vegf-A and insulin-like growth factor 1
directly into the target muscle following nerve injury and showed
improved functional reinnervation, citing an increased neuro-
transmitter or postsynaptic response. Similarly, exogenous alginate
gel Vegf-A delivery to ischemic muscle after nerve crush demon-
strated beneficial NMJ recovery effects: delayed Wallerian degen-
eration, AChR protection, and nerve growth factor-derived
and glial-derived nerve growth factor-dependent angiogenesis
(Shvartsman et al., 2014). Our study shows that Flk-1/VegfR2
exists in both myelinating SCs within nerve and
non-myelinating tSCs at the NMJ (Fig. 5).
These data suggest Vegf-A signaling induces
SCs to extend cytoplasmic processes to guide
the incoming regenerating axons at both the
nerve injury site (Gomez-Sanchez et al., 2017)
and the NMJ (Santosa et al., 2018). In the trans-
genic mouse, macrophage-derived Vegf-A is
diminished at all time points when tSC proc-
esses are decreased compared with controls
(Figs. 9, 10). Furthermore, increased Flk-1/
VegfR2 intensity in ECs around the NMJ com-
bined with higher Vegf-A expression levels
highlight the potential for increased vessel per-
meability, allowing additional immune cell
recruitment. Given the trophic role Vegf-A
plays in neurogenesis and angiogenesis in the
developing or posttraumatic nervous system
(Rosenstein et al., 2010; Shvartsman et al.,
2014), our results strongly indicate that Vegf-A
is integral to tSC morphologic changes during
NMJ reinnervation. The relationship of tSC
processes and angiogenesis requires additional
investigation. Interestingly, we showed Vegf-A
signaling inhibition via different mechanisms
resulted in decreased tSC cytoplasmic process
extension over a delayed time course; tSC
process extension is necessary for NMJ rein-
nervation. tSC processes normally extend
beginning 3d after nerve transection and di-
minish as NMJ reinnervation occurs or
over four weeks (O’Malley et al., 1999).
Since denervation would stimulate tSC pro-
cess formation (Reynolds and Woolf, 1992;
Son and Thompson, 1995; Rosenstein et al.,
1998; Koirala et al., 2000; Kang et al., 2014),
and we observed less tSC process extension,
these data suggest Vegf-A signaling changes
are directly linked to tSC process formation.
As tSC processes guide axons to the NMJ
(Reynolds and Woolf, 1992; Kang et al., 2003,
2014), altered tSC function likely contributed
to decreased NMJ reinnervation, resulting in
diminished muscle function in the absence
of Vegf-A signaling. Our data show tSCs
respond to immune environment alterations
and highlight the importance of tSC-macro-
phage (and macrophage-secreted Vegf-A)
interactions and tSC-nerve terminal interac-
tions. tSCs are key NMJ regulators contribut-
ing to NMJ signaling (Jahromi et al., 1992;
Reist and Smith, 1992; Corfas et al., 2004),
maintenance (Reddy et al., 2003; Barik et al.,
2016), and repair (Smith et al., 2013; Ko and Robitaille, 2015; Lee
et al., 2016). tSCs aid NMJ reinnervation by expressing Ccl2 to
recruit circulating monocytes (Fischer et al., 2008). tSCs, then,
may both initiate and interact with the cellular responses at the
NMJ after injury. Myelinating SCs are a target of macrophage
signaling; macrophages regulate SC differentiation and maturation
following nerve injury (Stratton et al., 2018). At the NMJ, tSCs are
similarly key interactors with macrophage-secreted Vegf-A.
The finding of an immune response downstream from the
nerve injury site, within the end target muscle, is novel. While
Figure 9. Vegf-A expression within macrophages is decreased in Vegf-Afl/fl; LysMCre mice. A, Vegf-A protein expres-
sion was significantly decreased in Vegf-Afl/fl; LysMCre mice at days 14 and 21 following nerve injury and repair. Vegf-A
levels peaked in both conditional knock-out mice and controls (Vegf-Afl/fl) at 21 d postinjury. B, Vegf-A mRNA expres-
sion was significantly decreased in Vegf-Afl/fl; LysMCre mice compared with the control mice. Vegf-A mRNA expression
peaked at day 21 in the Vegf-Afl/fl; LysMCre mice before significantly decreasing again at 28 d after nerve injury. C–H,
Macrophage (green) number was higher in the Vegf-Afl/fl; LysMCre mice compared with controls at days 7 and 28 after
nerve injury but did not differ between Vegf-Afl/fl; LysMCre mice and controls at days 14 and 21. Both groups had fewer
macrophages present in the muscle at day 28. G, The percentage of CD681 cells (green) colocalizing with Vegf-A
(red, white arrows in C–F), however, was significantly decreased in Vegf-Afl/fl; LysMCre mice compared with controls at
all time points. Macrophages not colocalized with Vegf-A are indicated by yellow arrows. Vegf-A Ab (red), CD68 Ab =
macrophages (green), DAPI = nuclear staining (blue). Scale bar: 20mm. Data: mean 6 SD; N= 3 mice/genotype/
time point; pp, 0.05.
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we conclude that tSCs interact with the
immune response at the NMJ, the mecha-
nisms triggering inflammation there
require further elucidation. Our results
contribute to literature regarding the im-
portance of the inflammatory response
distant from the nerve injury. After optic
nerve injury, downstream inflammatory
events, including increased CD681 cells,
have been described (Tonari et al., 2012).
Furthermore, unilateral optic nerve injury
leads to microglial inflammatory responses
in both the ipsilateral and contralateral
retinas (Sobrado-Calvo et al., 2007). Macro-
phages may impact tSCs at the NMJ in our
sciatic nerve transection model similarly to
microglial cells at the retina in an optic
nerve injury model. The presence of inflam-
matory effects downstream from the injury
site may have translational therapeutic
implications. Elicitation of the NMJ injury
response mechanisms are essential to our
understanding of motor recovery following
nerve injury and may have importance for
other organ systems as well.
Our data support previous reports
outlining benefits of inflammation for
recovery in multiple injury types. Macro-
phages, for example, are important for
cutaneous wound healing via promotion
of inflammation and angiogenesis; altera-
tions in macrophage phenotype influence
chronic wound formation (Koh and
DiPietro, 2011). Similarly, impaired
monocyte recruitment from the blood-
stream in Ccr2-deficient mice resulted in
impaired cutaneous wound healing that
corrected with WT monocyte and macro-
phage transfer (Boniakowski et al., 2018).
The importance of macrophage-driven
inflammation, including VEGF release,
for recovery has also been established in
models of liver injury (You et al., 2013),
as well as muscle (Arnold et al., 2007;
Shireman et al., 2007) and bone
(Alexander et al., 2011; Schlundt et al.,
2018) healing. In nerve, axonal regenera-
tion across a transection injury follows
the process of macrophage Vegf-A secre-
tion, followed by angiogenesis, SC migra-
tion across ECs, and finally axonal
regeneration along SC tubes (Jablonka-
Shariff et al., 2019). Inflammation,
although a commonly targeted patho-
physiological process, can be beneficial.
The immune system’s contributions to
healing are complex and multi-phased.
Neutrophils are the first (24 h) immune
cells to respond after injury. Although
they contribute to healing by phagocytosis of debris, they are not
essential (Martin and Leibovich, 2005). Infiltrating monocytes
are recruited to the injury site within 48–96 h via receptors such
as Ccr2, a promiscuous receptor that responds to a variety of sig-
nals, including Ccl2 and Ccl8 (Sondell et al., 1999a; Willenborg
et al., 2012; Jablonka-Shariff et al., 2019). Once in tissue,
recruited monocytes differentiate into inflammatory phenotype
Figure 10. tSC process extension is diminished after nerve injury in Vegf-Afl/fl; LysMCre mice. A, At day 7 after nerve injury,
tSCs extended their processes (arrow) in control mice. In contrast, tSC process extension was absent (arrow) at the NMJs in
Vegf-Afl/fl; LysMCre mice (B). Significant differences in tSC process extension persisted at days 14 (C, D) and 21 (E, F) postin-
jury. The inset in panel E shows an NMJ with a long tSC process (arrow) in control mice. The inset in panel F shows two end-
plates in Vegf-Afl/fl; LysMCre mice but only one (arrow) with a very short tSC process. By day 28, however, thinner tSC
processes were present in the NMJs of Vegf-Afl/fl; LysMCre mice (H) than in controls (G). I, Significant differences in the percent
of NMJs with tSC process extension was most evident from days 7 to 21. S100 Ab = glial cells (green), BTX = a-bungaro-
toxin (endplates, red), DAPI = nuclear staining (blue). Scale bar: 50mm. Data: mean6 SD; N= 3 mice/genotype/time point;
pp, 0.05.
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Figure 11. Innervation and functional NMJ recovery in Vegf-Afl/fl; LysMCre mice is persistently worse than controls. NMJ reinnervation, as seen by the colocalization of the neurofilaments
(green) with motor endplates (red, arrows), is shown at days 14 (A, B), 21 (C, D), and 28 (E, F) postinjury and nerve repair. G, NMJ reinnervation was significantly worse in the Vegf-Afl/fl;
LysMCre mice, achieving only half of the reinnervation rate of controls, at day 21. Vegf-Afl/fl; LysMCre mice showed a significantly lower percentage of fully innervated NMJs and higher percentage
of denervated (none) NMJs compared with controls. By day 28, both groups of mice were able to reach nearly 80% of motor endplates fully innervated. H, Vegf-Afl/fl; LysMCre mice demonstrated
significantly poorer CMAP performance at 21 and 28 d postinjury compared with control mice, indicating a functional impact extending beyond morphologic differences. NF200 Ab = axons
(green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale bar: 50mm. Data: mean6 SD; N= 3–5 mice/genotype/time point; pp, 0.05.
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macrophages, whereas later they tend to differentiate into reparative
phenotypes with resulting inflammation resolution (Lech and
Anders, 2013; Sciorati et al., 2016; Tomlinson et al., 2018).
Macrophages contribute to phagocytosis, but also facilitate healing
via cytokines and growth factor secretion, yielding immune cell
recruitment, angiogenesis, collagen deposition by fibroblasts, and
matrix synthesis (Janis and Harrison, 2016). Finally, macrophages
recruit T-lymphocytes by 5–7d after injury, which contribute to
healing via unclear mechanisms (Park and Barbul, 2004). Although
this immune cascade was initially studied in cutaneous wound heal-
ing, an analogous process takes place after nerve transection injury.
Despite the novel findings described here, this study has im-
portant limitations. Other cells near the NMJ may compensate
for altered conditions. In the circumstance of the Ccr2/mice,
for example, resident macrophages may compensate for absent
recruited macrophages. Although macrophages are the primary
Vegf-A source in muscle, ECs, for example, express Vegf-A and
explain the low levels of Vegf-A expression found in the
Vegf-Afl/fl; LysMCremice. Additionally, we see a delay between
NMJ morphologic changes and functional (CMAP) changes
in the different experimental models. This delay likely results
from poor sensitivity of CMAP testing early in reinnervation.
As mice have incomplete NMJ reinnervation normally at
two weeks after nerve cut and repair, differences between
groups cannot be elucidated from low CMAP values. In addi-
tion, we have previously found that CMAP corresponds to
complete and not partial NMJ reinnervation (Vannucci et al.,
2019). Additional work is necessary to determine the signal-
ing mechanisms at the NMJ following injury.
In conclusion, this study demonstrates multiple key findings
regarding target muscle functional recovery after nerve injury.
An inflammatory response occurs at the muscle, distant from the
site of nerve transection. Macrophages are integral for NMJ rein-
nervation after injury. Vegf-A signaling is necessary for tSC pro-
cess extension, timely NMJ reinnervation, and muscle function
after reinnervation. Thus, macrophage-secreted Vegf-A is inte-
gral for NMJ recovery at the end target muscle after nerve injury.
Our proposed mechanisms occurring at the NMJ are summar-
ized in Figure 12. Circulating monocytes are recruited into mus-
cle via Ccl2–Ccr2 interactions. Macrophages then secrete Vegf-
A, which may act on tSCs, facilitating tSC process extension to
induce axonal sprouting and guide axons to the NMJs. Vegf-A
also induces angiogenesis, allowing delivery of additional circu-
lating cells and guidance of tSC processes, and may also interact
with nerve terminals. Additional investigation is warranted to
further elucidate the details of these cellular processes at the NMJ
following nerve injury.
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